Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.

L Kanerud, G N Engström, A Tarkowski

Department of Rheumatology, Karolinska Institute, Stockholm Söder Hospital, Sweden.

OBJECTIVE--To study the effects of sulphasalazine (SASP) on the systemic and mucosal humoral immune systems in patients with rheumatoid arthritis (RA). METHODS--Serum concentrations of interleukin 6 (IL-6), class and subclass specific IgG, IgA and IgM, IgA and IgG antigliadin antibodies and rheumatoid factors (RF) of IgG, IgA (including IgA1 and IgA2 subclasses) and IgM isotypes were measured before and 16 weeks after sulphasalazine (SASP) therapy in 15 female and three male patients with RA. Amounts of immunoglobulins in saliva and jejunal fluid were measured as estimates of mucosal humoral immunity. RESULTS--Serum concentrations of IgA and IgG decreased significantly during SASP therapy and correlated with reduced concentrations of IL-6. In addition, levels of circulating IgA RF, IgA anti-gliadin antibodies and IgM RF decreased significantly after the treatment. In contrast, immunoglobulin levels in saliva and jejunal fluid were unaltered. CONCLUSION--SASP exerts powerful but selective inhibitory effects on systemic immunoglobulin production, whereas no effects on mucosal immunoglobulin production were observed. The decreased systemic B cell activity may be mediated by downregulation of the production of IL-6, a cytokine with Ig switching properties.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hvatum, M, Kanerud, L, Hallgren, R, Brandtzaeg, P (2006). The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis. Gut 55: 1240-1247 [Abstract] [Full Text]  
• Ronnelid, J, Wick, M C, Lampa, J, Lindblad, S, Nordmark, B, Klareskog, L, van Vollenhoven, R F (2005). Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64: 1744-1749 [Abstract] [Full Text]  
• Gunnarsson, I., Nordmark, B., Hassan Bakri, A., Grondal, G., Larsson, P., Forslid, J., Klareskog, L., Ringertz, B. (2000). Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment--the role of IL-10 and HLA. Rheumatology (Oxford) 39: 886-893 [Abstract] [Full Text]  
• Mäki-Ikola, O., Hällgren, R., Kanerud, L., Feltelius, N., Knutsson, L., Granfors, K. (1997). Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 56: 421-425 [Abstract] [Full Text]